|
Mother And Child Medical Services |
|
The information contained at the Jachabacha Web site
should not be used as a substitute for the medical care and advice of your physician. Information
provided here pertains to Medicine in general. There may be variations in treatment recommended by your physician based on
individual facts and circumstances. |
Mother To Child Transmission
Back
To MCMS Health And Medicine Journal.....![]()
Focusing On Antiretroviral Therapy For Prevention Of
Maternal To Fetal HIV Transmission
Regimens
q
Long
Course Zidovudine Treatment
q
Short
Course Zidovudine Treatment
q
Combination
Therapy
Long
Course Zidovudine Treatment
|
Period Of Time |
Route |
Dosage (ZDV) |
|
|
|
|
|
During
Pregnancy, initiate at 14 - 34 wks gestation |
Oral |
100mg 5 times
a day |
|
|
|
|
|
During Labour
And Delivery |
Intravenous |
2mg /kg
during the first hour (loading), then 1mg / kg / hour until delivery |
|
|
|
|
|
For The
Newborn, Beginning 8-12 Hours After Birth |
Oral |
2mg /kg 4
times a day |
The Trial:
Pediatrics AIDS Clinical Trial Group (PACTG 076)
§
But
Data Suggest From Thailand And Brazil Suggest A Good Efficacy Of This Regimen
ü
Women given ZDV (100mg 5times a day) Or Placebo
starting at 14-34 weeks (median 26 weeks)
ü
Received ZDV during Labour and Delivery. Newborns
received ZDV at 8-12 hours as mentioned above
ü
All
mothers had CD4 counts > 200 were symptom free and had not received
antiretrovirals before
Results Of The PACTG076 trials
|
HIV
Transmission Rate |
|
|
ZDV Treated Group |
Placebo Group |
|
8.3% |
25.5% |
Almost 67% reduction in
transmission (356 mother child groups
analysed)
References:
AIDS Clinical Trials Group
Protocol (Center For Disease Control And Prevention), Recommendations for use of
of zidovudine to reduce perinatal transmission of human immunodeficiency virus,
MMWR, 1994; 43 (No. RR - 11) I-20
Data From Red Book,
American Academy Of Pediatrics, 1997
Data From Who Paper HIV In
Pregnancy : A Review
Newell M-L, Gray G, Bryson
YJ. Prevention of mother to child HIV - I transmission. AIDS, 1997, 11 (Suppl A)
: S165-S172
Certain Limitations When Applied To
The Developing Countries:
q
The Study reviewed only non - breast feeding mothers
q
Cost: The Regimen costs about US$ 1000
q
Intervention needs to be introduced early when most women in
resource poor countries attend antenatal care late in pregnancy
The
use of shorter regimens or other antiretrovirals provides an alternative
Short
Course Zidovudine Treatment
ü
More
feasible in resource poor countries
The Bangkok Perinatal AZT Study, 1996:
ü
Randomized placebo controlled trial
ü
All women given infant feeding formula and advised not
to breast feed
|
Period Of Time |
Route |
Dosage (ZDV) |
|
|
|
|
|
From 36 weeks
Pregnancy Till Onset Of Labour |
Oral |
300mg twice
daily |
|
|
|
|
|
Onset Of
labour Till Delivery |
IV |
300mg every 3
hours |
Results Of The Bangkok Perinatal AZT Study
|
HIV
Transmission Rate |
|
|
ZDV Treated Group |
Placebo Group |
|
9.4% |
18.9 |
Almost 50% reduction in transmission (May
1996 - December 1997 : 393 mother child pairs analysed)
Reference:
Schaffer N et al. Short Course zidovudine for perinatal HIV - 1
transmission in Bangkok, Thailand: a randomized control trial. Lancet March
1999, 353 : 773 - 80
The Cote d'Ivoire Trial:
ü
Randomized placebo controlled trial
ü
Over 95% of the infants were breast fed
|
Period Of Time |
Route |
Dosage (ZDV) |
|
|
|
|
|
From 36 weeks
Pregnancy Till Onset Of Labour |
Oral |
300mg twice
daily |
|
|
|
|
|
Onset Of
labour Till Delivery |
Oral |
300mg every 3
hours |
Results Of The Cote d'Ivoire Trial
|
HIV
Transmission Rate |
|
|
ZDV Treated Group |
Placebo Group |
|
19
Of 115 Babies (16.5%) |
30
Of 115 Babies (26%) |
Almost 36% reduction in transmission (119
mother child groups analysed)
Reference:
Dasbis F et al for the DITRAME Study Group 6 month efficacy, tolerance
and acceptability of a short course regimen of zidovudine to reduce vertical
transmission of HIV in breastfed children in Cote d'Ivoire : a double blind
placebo control multicentric trial. Lancet, 1999, 353 : 786-92
Combination
Therapy
The UNAIDS co-ordinated PETRA trial using Zidovudine +
Lamivudine
ü
Study still in progress but interim results at 6 weeks
of age infants available
ü
Compares 3 different regimes versus a placebo in
Breastfeeding Population
Drugs: Zidovudine + Lamivudine
|
Drug Arm |
Therapy |
|
|
|
|
A |
From 36 weeks Pregnancy, During Labour And For One
Week Post Partum To Both Mother And Child |
|
B |
From Onset Of Labour And For One Week Post Partum
To Both Mother And Child |
|
C |
During Labour Only |
Results Of The UNAIDS co-ordinated PETRA trial
|
Drug Arm |
HIV Transmission Rates |
|
|
|
ZDV Treated Group |
Placebo Group |
|
|
|
|
|
A |
8.6% |
17.7% |
|
B |
10.8% |
|
|
C |
17.2% |
|
(1790 mother child
groups analysed)
Others -
Nevirapine: Efficacy studies have commenced on Neirapine (NNRTI)
as the drug achieves high circulating levels which are long lasting
raising the possibility of a one dose treatment in labour : Results
Awaited
Thank You.
Send In Your Comments To jachabacha@yahoo.com
Back
To MCMS Health And Medicine Journal.....![]()